Topics
Gliomas | Treatment | Immunotherapy | Pembrolizumab
Home > Publications > Topics > Gliomas > Treatment > Immunotherapy > Pembrolizumab
Baldini C, Cassier PA, Delord JP,
Simonelli M, Touat M, Yao L, Duic JP, Gozman A, Marabelle A.
Pembrolizumab
monotherapy for microsatellite instability-high or mismatch repair
deficient recurrent gliomas: results from the multicohort
KEYNOTE-158 study.
J
Neurooncol. 2026
Apr 1;177(2):85. doi:
10.1007/s11060-026-05461-2. PMID:
41920388. Trial
registration ID:
NCT02628067˰
ˍ